Barts Early Post-Acute Myocardial Infarction Discharge Registry

What this Trial Is About

Coronary artery disease (CAD) remains a leading cause of death worldwide despite improvements over time. Advances in minimally invasive treatments have improved patient outcomes, but real-world data on intervention and treatment safety and effectiveness are needed. This research focuses on patients with acute coronary syndrome discharged early after primary percutaneous coronary intervention (PCI) to better understand their characteristics and outcomes, helping improve risk assessment and care strategies. The study uses a large clinical database from a major cardiac center in Europe, including patients admitted with acute coronary syndrome and discharged early after PCI. This observational registry collects demographic, clinical, and outcome data on patients with a range of CAD complexities. The research aims to assess the safety and feasibility of the early discharge pathway and explore predictors of outcomes and complications following interventional treatment. Participants' data are collected and analyzed over one year, including medication adjustments, major adverse cardiac events, and quality of life assessments. The study uses secure databases and monitors patient outcomes to provide real-world evidence on early discharge after heart attack treatment. The findings intend to inform local and global care practices and stimulate further research in underexplored areas of cardiac care.

Early Discharge Pathway Registry